The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations
Transl Lung Cancer Res
.
2018 Apr;7(Suppl 2):S134-S137.
doi: 10.21037/tlcr.2018.03.08.
Authors
Lore Decoster
1
,
Philippe Giron
1
,
Sacha Mignon
1
,
Jacques De Grève
1
Affiliation
1
Department of Medical Oncology, Oncology Centre, Universitair Ziekenhuis (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussel, Belgium.
PMID:
29780706
PMCID:
PMC5943217
DOI:
10.21037/tlcr.2018.03.08
No abstract available
Publication types
Editorial
Kommentar